tionally modified recombinant biotherapeutics from robust cells in a cost-effective manner. Strategies to increase productivity include cellular engineering of cell lines, sub-cloning to isolate high producing clones, geneamplification systems (DHFR/MTX and GS/methionine sulphoximine (MSX) systems), process development (batch, fed-batch, perfusion, etc.), and media optimization [1] . The large number of recombinant biotherapeutic candidates entering different stages of development has placed increasing pressure on the biopharmaceutical companies to accelerate cell-culture development to deliver this pipeline and contain development costs. Cellculture development, including strain selection, process optimization (medium formulation), and scale up, has traditionally been a labor-intensive process that is limited by the number of conditions that can be tested.
In recent years, there have been significant efforts to develop high-throughput (HT), miniaturized cell-culture systems that can improve the efficiency of the development process by allowing HT parallel operation, while reducing the cost of reagents, thus permitting the exploration of a vast space of culture conditions. HT platforms serve as a cost-efficient and rapid screening method for evaluating the effect of cell-culture conditions and screening of chemicals, including novel drugs in cell-culture systems [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . In addition, commercial systems such as deep well, and AMBR/TAP systems have been utilized for evaluating cell-culture systems. However, to date, there is no universal platform for optimizing cell-culture development. A three-dimensional (3D) cell-culture chip (the microarray DataChip) was developed that can be utilized to perform rapid screening of the effects of culture medium on cell growth rate, maximum viable cell density, and protein expression levels. The microarray DataChip, which can contain up to 1080 individual mammalian cell cultures on a microscope-size glass slide (chip), has been used to cultivate a wide range of human and animal cell lines (liver, breast, pancreatic, colon, neural) and primary cells (hepatocytes, astrocytes, cardiomyocytes), as well as embryonic and adult stem cells [4, 10] . The HT cell-culture platform has the potential to be utilized for drug discovery (e.g. evaluating impact of novel drugs), human toxicology studies (e.g. evaluating potent anthropogenic compounds), and media optimization (e.g. evaluating impact of media components on cell growth and recombinant protein production).
Media development has been used to optimize CHO cell growth and/or the transgene expression in bioprocesses [14] [15] [16] [17] . Media components such as carbon source, nitrogen sources, copper sulfate, manganese sulfate, and zinc sulfate and bioreactor temperature, pH, and shear stress can also impact cell growth, productivity, and post-translational modifications of the transgenic protein produced [2, [17] [18] [19] [20] [21] [22] [23] . There are two strategies to increase productivity in cell lines with media optimization (i) increase specific productivity (i.e. amount of recombinant monoclonal antibody produced per cell of a bioreactor/day) and (ii) increase cell yield (i.e. the total integrated viable cell density (IVCD) for the culture duration). The aim of this study is to develop a HT microarray DataChip platform for examining the effect of media components on cellular processes, such as, growth, productivity, metabolism, and its potential application towards on-chip metabolic pathway studies. In this work, first, (i) a defined non-proprietary medium was optimized for growth of a recombinant monoclonal antibody-producing GS/MSX CHO cell line, followed by (ii) optimization of a 3D HT microarray platform for studying the effects of different concentrations of media additives on cell growth, metabolism, and productivity, and (iii) validation of the 3D HT platform in conjunction with the conventional scaleup shake flask platform. The 3D HT platform consists of DataChip microcultures separated in groups via an 8-well chamber system attached to the chip. Live-dead assays performed on the microarray spots, in conjunction with IgG competition assays and metabolite analysis, provide quantitative information on cell growth, protein production, and metabolism. In addition, cell-conditioned medium was utilized to study the glycosylation pattern of the product using hydrophilic interaction chromatography (HILIC)-Fourier transform mass spectrometry (FTMS).
Materials and methods

Optimization of a non-proprietary medium and adaptation of CHO cells in the non-proprietary medium
A recombinant GS/MSX CHO cell line (CHO-A1, which produces a proprietary monoclonal antibody immunoglobulin type G (IgG), 150 kDa), was provided by J&J, Janssen Biotech and used as the model cell line. In addition, the host GS/MSX CHO cell line (CHO-H1) was also provided by J&J, Janssen Biotech. A non-proprietary medium previously designed for the growth of DHFR/MTX CHO cell lines was used as the starting point for this study [19] . The non-proprietary medium was modified for the growth of the model recombinant CHO-A1 cell line and host CHO-H1 cell lines. The non-proprietary medium (Table 1) was prepared in sterile glass bottles. Following addition of all the supplements, the medium was stirred for 1 h, and the pH was subsequently adjusted to 7.0. The medium was filter sterilized and stored at 4°C. Prior to use, the medium was supplemented with insulin (SigmaAldrich, St. Louis, MO, USA) and 1% penicillin-streptomycin (Sigma-Aldrich). The host cells (CHO-H1) required addition of 20 mL of Glutamax supplement (Invitrogen) per 500 mL of medium, while the transfected cell lines were supplemented with 25 µM of GS inhibitor MSX. The proprietary CHO cells, CHO-H1 and CHO-A1, were directly adapted to grow in non-proprietary medi-um. The cell lines were seeded in 47 mL of medium at 3 × 10 5 cells/mL in 125 mL polycarbonate Erlenmeyer flasks (Corning, Corning, NY) and cultured on orbital shakers agitated at 125 rpm in a humidified 37°C incubator and 5% CO 2 . Growth rates were analyzed by manual cell counting using trypan blue to estimate cell viability and viable cell density, according to the standard operating protocol provided by J&J, Janssen Biotech. Briefly, cells were diluted with equal volume of Trypan Blue solution and cells were counted using a hemocytometer and quantified using the following equation:
(1)
Preparation of 3D microarray cultures
The CHO cells were cultured in 3D microarrays by embedding them in alginate, and printing the solution mixture in 60 nL spots onto hydrophobic glass slides. Briefly, a poly-L-lysine (PLL)-BaCl 2 mixture was prepared by mixing a sterile 0.1 M BaCl 2 solution in deionized water with a 0.01% w/v sterile PLL solution (Sigma) in a 1:2 volume ratio. The PLL-Ba 2+ mixture was spotted onto poly(styrene-co-maleic anhydride) (PSMA) coated glass slides using a MicrosSys 5100-4SQ microcontact microarray spotter (DigiLab), making a 6 × 8 × 8 patterned array of 60 nL spots on the chip and allowing them to dry. A CHO cell suspension in medium was then mixed with a low viscosity alginic acid (Sigma) solution in deionized sterile water such that the final alginate concentration was 1% w/v, and the concentration of cells in suspension was 3.3 × 10 6 cell/mL. Subsequently, the cell-alginate mixture was printed (60 nL/spot, 200 cells/spot) on top of the dried PLL-Ba 2+ spots, which allowed the nearly instantaneous gelation of the alginate matrix. During the printing process, the humidity in the microarray chamber was maintained above 90% to prevent water evaporation of the spots. Following printing, the slides were fitted with a commercially available 8-well polystyrene medium chambers coated with a biocompatible adhesive (Lab-Tek II, Nunc) that allowed firm attachment of the chips to the chambers, and physically separated groups of spots within the slide. Each of the chambers, containing 48 cell-culture spots, was filled with 250 µL of non-proprietary medium. After medium addition, the chambers were covered with gas-permeable sealing membranes (Diversified Biotech), and the chips placed in segmented dishes (Thermo Scientific Nunc) with the surrounding wells filled with sterile deionized water to prevent media evaporation. The cells were then cultured at 37°C in a 5% CO 2 humidified incubator. Terminal harvest samples taken at different culture time points were generated by carefully removing the medium from one of the replicate chips, weighing the resulting mass of medium to assess the percentage of evaporation, and freezing the samples at -20°C. Following media recovery, chambers could be easily removed with a slide separator.
Cell viability assay
Cellular viability and growth on the 3D microarrays was assessed via a live/dead viability/cytotoxicity kit for mammalian cells (Invitrogen). After complete media recovery, the slides were separated from the chamber, and subsequently rinsed twice with a wash solution Viablecells / mL viablecell number squarescounted dilution factor 10 4 (140 mM NaCl (Sigma-Aldrich) and 20 mM CaCl 2 (Sigma) at pH 7). The slides were then immersed in a 0.5 µM calcein AM/ethidium homodimer 1 solution to detect viable and dead cells via green and red fluorescence, respectively. After 45 min of incubation at room temperature, the dye was removed and the chips rinsed thoroughly with the wash solution and then dried. The slides were finally scanned with a GenePix 4200A scanner (Molecular Devices) using 488 nm excitation, with a standard blue filter and a 645AF75/594 filter for detection of the green and red dye, respectively. The fluorescence intensity from the resulting image was quantified with the GenePix Pro 6.0 software (Molecular Devices), and the cell number in each spot estimated based on a 6-point "viable-cell" standard curve prepared on the same day of printing. Determination of viability required the fabrication of a separate calibration curve for dead cells. This was achieved by permeabilizing the cells in calibrator samples with 0.15% saponin for 30 min, followed by live-dead staining. The ratio of the ethidium homodimer 1 fluorescence signal from the viable-cell standards to the dead-cell standards (total number of cells) yields the viability of the calibrators.
Evaluation of media additives in microarray DataChip and shake flask platforms
Media additives, pyruvate (Invitrogen), MEM non-essential amino acids (Invitrogen), MEM vitamins (Invitrogen), Mn 2+ (Sigma-Aldrich), and glutamate (Sigma-Aldrich) were added at appropriate concentrations and pH was adjusted to pH 7.0. The medium was sterilized by filtration with a 0.22 µm syringe filter and stored at 4°C. On the day of the experiment, media were set at room temperature and were supplemented with 2% HT supplement, 1% penicillin-streptomycin, and insulin. The media were utilized in DataChip and/or shake flask platforms. For HT evaluation of the effects of media additives using the DataChip, recombinant CHO-A1 cells were seeded onto the DataChip in the various media. The cells were cultured in a humidified 37°C incubator at 5% CO 2 for 8 days. Throughout the growth period, samples were analyzed by live-dead viability assay to determine the growth rates. When the samples were sacrificed for live-dead assays, cell-conditioned medium was collected and stored at -20°C for further analysis.
For validating the DataChip results, selected media additives were evaluated in parallel in a shake-flask platform. For shake-flask studies, recombinant CHO-A1 cells were seeded at 2 × 10 5 cells/mL in a volume of 47 mL of medium in polycarbonate Erlenmeyer flasks (Corning) and cultured on orbital shakers agitated at 125 rpm in a humidified 37°C incubator at 5% CO 2 . Cells were cultured until the cell viability dropped to 50%. Growth rates were analyzed by manual cell counting using trypan blue to estimate cell viability. Additionally, cell-conditioned medium was collected periodically at different timepoints and stored at -20°C for evaluating recombinant antibody production, and metabolite profiling.
Meso Scale Discovery (MSD) competition assay for IgG titer
The amount of recombinant monoclonal antibody (IgG1) production was determined using a competition assay on MSD's low-capacity Protein A coated plates, in the presence of a SULFO-TAG™-labeled IgG tracer. SULFO-TAG™-labeled IgG tracer was prepared by tagging positive control IgG with MSD SULFO-TAG NHSEster (Meso Scale Diagnostics #R91AN) according to the manufacturer's directions. Briefly, a 2-mg/mL solution of the IgG was prepared in preservative-free PBS, pH 7.9. The IgG solution was incubated with 32 nmol of MSD SULFO-TAG NHS-Ester (50 µL) at 23°C for 2 h in dark. This labeling reaction was purified with a pre-calibrated 40K MWCO ZEBA spin desalting column (Thermo Scientific #87766), according to the manufacturer's instruction. The conjugation ratio was calculated using the following equation: (2) In this equation, A 455 is the absorbance of the SULFO-TAG IgG conjugate at 455 nm, MW IgG is the molecular weight of the protein, ε sulfo-tag is the extinction coefficient of the SULFO-TAG at 455 nm (15 400 M -1 cm -1 ), and C IgG is the concentration of the protein conjugate determined using the BCA assay. The antibody was aliquoted and stored frozen at -20°C.
SULFO-TAG™-labeled IgG tracer (stored at -20°C) was used for determining IgG amount in the cell-conditioned medium. The IgG is a secreted antibody that is collected in the cell-conditioned medium. Cell-conditioned medium (1 mL) was collected on specified days and the corresponding viable cell density was noted. The cell-conditioned medium was collected by centrifugation of the cells and cell-conditioned medium at 200g for 10 min and stored at -20°C. The cell pellet was discarded. The MSD IgG competition assay was performed on the cell-conditioned medium according to the manufacturer's protocol (MSD ® 96-well competition assay kit for IgG). Briefly, the lowcapacity protein A-coated MSD plate was blocked with 100 µL of diluent 100 in each well, at room temperature for 1 h, followed by removal of the diluent 100 by washing three times with 50 µL of PBS/0.05% Tween-20. Mixtures of equal volumes of SULFO-TAG™-labeled IgG tracer and dilutions of control IgG tracer (ranging from 0 to 100 µg/mL) were used to generate a standard curve. The mixtures of cellconditioned medium and control IgGs (50 µL per sample in each MSD well) were loaded on to the washed low-capacity protein A-coated MSD plate and incubated for 2 h with vigorous shaking (500 rpm) at room temperature. The MSD 
where t is time and X is the viable cell concentration. The cell and mAb concentrations above were corrected for the measured medium evaporation. Data were analyzed with Student's t-test to determine statistical differences between independent samples.
Results and discussion
Development of a non-proprietary medium for growth of recombinant CHO cells
The first critical step of the project was to establish growth of the model CHO cell lines in a defined non-proprietary medium. A non-proprietary medium that had been developed for the growth of DHFR/MTX CHO cell lines was used as the starting point [19] . This non-proprietary medium was modified for the growth of the GS/MSX CHO cells (Table 1) . During direct adaptation of the cells to the non-proprietary medium, it was observed that addition of 2% hypoxanthine-thymidine supplement (Gibco) was necessary to allow adequate cell growth, viability, and production of mAb. Cell growth and recombinant antibody production in the proprietary and defined nonproprietary medium were evaluated (Supporting information, Fig. S1 ). In addition, the glycoprotein secreted from the CHO-A1 cell line grown on non-proprietary medium was collected from 20 mL of medium recovered from shake flask culture. Treatment of recovered IgG glycoprotein with PNGaseF and analysis of released N-glycans showed three biantennary structures each with a bisecting fucose and containing 0, 1, and 2 sialic acid residues (Supporting information, Fig. S2 ). Thus, the defined nonproprietary medium developed allows for normal glycosylation of IgG glycoprotein.
Design and optimization of a microarray DataChip platform for CHO cell growth
HT platforms for evaluating impact of media components on cellular processes, including recombinant protein production, are of critical importance. Based on the previous DataChip microculture platform [10] , a 3D microarray chip was designed that is ideally suited to examine the effects of culture medium on CHO cell growth and specific mAb expression (Fig. 1A) . A commercially available 8-well
plates were washed three times with 50 µL of PBS/0.05% Tween-20 and 150 µL of 1× Read Buffet T was added to each MSD well. The MSD plate was analyzed on the SEC-TOR ® Imager (Meso Scale Diagnostics). The amount of IgG present in cell-conditioned medium was calculated based on the standard curve. The data was analyzed with MSD DAT software, which fits the standard curves using a four parameter logistic fit with 1/y 2 weighting:
where x is the concentration, b 2 the estimated response at infinite concentration, b 1 the estimated response at zero concentration, b 3 is the mid-range concentration, and b 4 is the slope factor.
Glycan analysis
N-Linked oligosaccharides of the antibody were released by treatment with PNGase F (Sigma-Aldrich) overnight at 37°C following the protocol provided by SigmaAldrich. After releasing the N-glycans, the antibody was precipitated by addition of ethanol followed by centrifugation. The supernatant was dried in a SpeedVac and stored at -80°C for liquid chromatography-mass spectrometry (LC-MS) analysis. The released N-glycans were analyzed on a hydrophilic interaction chromatography column (2.0 mm × 50 mm, Phenomenex Luna HILIC, Torrance, CA) coupled with electrospray ionization on an LTQ-Orbitrap XL FTMS (Thermo Fisher Scientific, San Jose, CA). Mobile phase A was 5 mM ammonium acetate prepared with HPLC-grade water. Mobile phase B was 5 mM ammonium acetate prepared in 98% HPLC grade acetonitrile with 2% of HPLC grade water. An Agilent 1200 HPLC binary pump was used to deliver the gradient from 10 to 80% A over 8 min at a flow rate of 250 µL/min after injecting the samples. The optimized MS parameters included a spray voltage of 4.2 kV, a capillary voltage of -40 V, a tube lens voltage of -50 V, a capillary temperature of 275°C, a sheath flow rate of 30 L/m, and an auxiliary gas flow rate of 6 L/m. External calibration of mass spectra routinely produced a mass accuracy of better than 3 ppm. All Fourier-transform mass spectra were acquired at a resolution 60 000 within 400-2000 Da mass range.
Metabolite analyses
Metabolite analyses were performed using either a YSI 7100 MBS (YSI Inc., Yellow Springs, OH) or a BioProfile FLEX (NOVA Biomedical, Waltham MA).
Data analysis
The specific growth rates, µ, were obtained from the exponential growth phase of the culture. This growth
chamber system was attached to the DataChip to allow the screening of a number of medium additives provided to the wells, each of which contained 48 separate microcultures (60 nL/spot, 200 cells/spot) in an alginate matrix. By bringing the two together, the effects of the medium composition and solution conditions on cell growth could be determined in the DataChip using simple live-dead staining. Figure 1B Cell growth was determined using cell viability assay. Recombinant monoclonal antibody production was determined with MSD competition assay. Data represents the mean ± SE of an experiment with 190 replicate microcultures for the livedead assay, and two replicate conditioned media samples for antibody production.
integrity of microcultures during prolonged incubation. The small volumes of medium used in the chip cultures (250 µL/well) led to significant media evaporation throughout the course of the experiments, which caused important deviations in nutrient and metabolite concentration with culture time. This issue was addressed by both measuring precise changes in media mass with time to account for the evaporation and preventing evaporation through increased humidity in the environment (Supporting information, Fig. S4 ). In addition, brightfield microscopy images of the microcultures revealed some cell detachment from the alginate spots after 8 days of culture, whereas spot integrity was intact for previous samples (Supporting information, Fig. S5 ). This is probably due to the alginate matrix deterioration, as well as cell over-growth at long incubation times. Thus, terminal batch experiments up to only 6 or 7 days are possible with the current microarray setup.
Application of the microarray DataChip for evaluating media components on cellular processes
The HT DataChip platform was further utilized to evaluate impact of media additives (glucose, pyruvate, vitamins, non-essential amino acid, manganese, zinc, and copper) on cellular processes, including recombinant antibody production ( Fig. 2 and Supporting information, Figs. S6-S10). It is important to note that evaporation rates of media for this experiment were substantial, as depicted in Supporting information, Fig. S11 ; however, the appropriate corrections in the measured concentrations were performed. The effect of varying the concentration of glucose and pyruvate was examined, due to the importance of these compounds as carbon sources in glycolysis. The results show a significant decrease in cell growth with increas- Figure 2 . Application of the DataChip for media optimization. Changes in (A) cell growth, and (B) productivity in response to variations in glucose (4, 4.8, 5.5, 7, and 10 g/L), pyruvate (0.08, 0.1, 0.14, and 0.19 mg/mL), and MEM vitamins (0×, 1×, 2×, and 4× to 2× concentration of the solution). Cell growth was determined using cell viability assay. Recombinant monoclonal antibody production was determined with MSD competition assay. Cell growth analysis data represents the mean ± SE of an experiment with 48 replicate microcultures and pooled spent media from the 48 microcultures for antibody productivity analysis.
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ing glucose concentrations ( Fig. 2 and Supporting information, Fig. S6 ). With small increases in glucose concentration, slight increases in titer were also seen with a maximum titer of ~22 µg/mL at 5.5 g/L of glucose (specific productivity ~27 pg/cell/day). However, at higher glucose concentrations (≥7g/L), the overall titer was reduced, despite apparent increases in specific productivity due to the lower IVCD. These results are important since rigorous control of glucose concentrations is often necessary to minimize by-products, such as lactate and ammonia, and thus prevent media acidification. The addition of pyruvate led to a moderate increase in cell growth and a concomitant decrease in recombinant monoclonal antibody production with respect to the base medium, which ultimately resulted in a decrease in productivity at high pyruvate concentrations, from roughly 14 pg/cell/day in base conditions (0.08 mg/mL pyruvate) to 9 pg/cell/day at pyruvate concentrations of 0.19 mg/mL ( Fig. 2 and Supporting information, Fig. S6 ). In contrast, the addition of increasing concentrations of a MEM vitamin solution negatively impacted both cell growth and mAb production, resulting in extremely low productivities at the higher vitamin concentrations (~1.5 pg/cell/day; Fig. 2 and Supporting information, Fig. S6 ). It was expected that MEM non-essential amino acids solution would enhance recombinant antibody production, since amino acids serve as the building blocks of proteins. These results show an increase in cell growth up to 2× concentrations of the amino acid solution that is offset by a similar increase in mAb concentration, resulting in nearly constant productivity (Supporting information, Fig. S7 ). In addition, variations of Mn 2+ (Supporting information, Fig. S8 ), Cu 2+ (Supporting information, Fig. S9 ), and Zn 2+ (Supporting information, Fig. S10 ) on cell growth and productivity were analyzed. In all the chip platform experiments, growth data represents average (± standard error) of 48 technical replicates. The growth data does include the standard error, but it is small because of the large number of replicate cultures. Due to the miniaturization of the chip platform, the spent media from the 48 technical replicates were pooled to generate productivity data. Due to the fact that these experiments did not have biological replicates, it is difficult to discern if the changes in productivity observed are statistically significant. In parallel, similar experiments were performed in conventional shake flasks comparing similar concentrations of pyruvate, MEM amino acids and Mn 2+ as the 3D HT DataChip platform (Supporting information, Fig. S12 ). In agreement with the Chip platform, the shake flask data showed that there was no significant differences in cell growth due to addition of various concentrations of pyruvate, MEM amino acids, and Mn 2+ to the base medium (Supporting information, Fig. S12 ). Metabolite analysis of the spent media from samples obtained from shake flasks were conducted with BioProfile FLEX on cell-conditioned media from the shake flask experiments highlighted that the glutamate concentration used in the non-proprietary formulation was 20-fold lower than what is typical in the proprietary medium formulation (data not shown). Glutamate is an essential amino acid and is an important source for production of glutamine [18] . Therefore, the 3D HT DataChip platform was utilized to evaluate effect of glutamate on cell growth and metabolism, and further crosscheck with the conventional shake flask platform. In addition, it was also observed that due to technical errors, there might be variability in preparation of the non-proprietary medium (Table 1) , for example minute changes in pH of initial base media influence cell growth and productivity and pH was adjusted at 7.0. Therefore, for all experiments, two 1 L flasks of base medium were prepared and sterilized at a time in parallel, that was kept in 4°C and used for experiments (within 2 months). In addition, our initial experiments showed that minute changes in the temperature, humidity and CO 2 levels of the incubator could impact our study. For consistency, all the experiments were performed in the same incubator, accommodating the shake flasks and 3D HT DataChips.
Glutamate addition and endogenous lactate consumption
The addition of 5 and 10 mM glutamate from the base condition of 0.3 mM led to a modest increase in cell growth in the 3D microarray DataChip platform (Fig. 3A, B) . Metabolite analysis on cell-conditioned medium from the chip samples was performed using an YSI analyzer. Figure 3 demonstrates the effect of glutamate concentration on glucose consumption (Fig. 3C ), lactate formation (Fig. 3E) , and glutamate metabolism (Fig. 3G) . The data is helpful in illustrating the adequate preparation of the medium as it concerns glucose and glutamate addition. The data also demonstrates that glucose is not depleted throughout the course of the 8-day experiment. An interesting increase in lactate concentration with increasing glutamate concentration was also observed.
The glutamate experiments were replicated in the shake flask platform (Fig. 3B) . The base medium contained 0.3 mM glutamate. Addition of 5 and 10 mM glutamate demonstrated a modest increase in the cell growth in the CHO-A1 cells (Fig. 3B) . Figure 3 demonstrates effect of glutamate concentration on glucose consumption (Fig. 3D) , lactate formation (Fig. 3F) , and glutamate metabolism (Fig. 3H) in the CHO-A1 cells. The trend of glucose consumption and glutamate concentrations in both DataChip (glucose, Fig. 3C; glutamate, Fig. 3G ) and shake flasks (glucose, Fig. 3D; glutamate, Fig. 3G ) were similar. The lactate production in the Datachip (Fig. 3E ) and shake flask (Fig. 3F) were similar; however, a decline in lactate concentration on day 3-4 in shake flask suggested lactate consumption for the highest glutamate concentration (glutamate concentration 10.3 mM, Fig. 3F ). Indeed, some difference in cellular bioprocesses, such as cell growth and mAb expression, might be reasonably expected in the two platforms. One of key differences between the two platforms is the cell density (10-fold difference in initially seeding density), which is expected to lead to varying degrees of nutrient availability and metabolite accumulation.
Lactate production leads to decrease in cell growth and productivity [22, 24] . Lactate consumption by cells occurs under optimal conditions, resulting in a metabolic shift [21, 22] . We observe that the GS/MSX CHO cells grown in base medium supplemented with 10.3 mM glutamate exhibit a metabolic shift on day 3-4 when cultivated in shake flasks, resulting in lactate consumption. It has been shown that specific changes in metabolic pathways lead to this lactate metabolic shift [22, 25, 26] . A potential usage of the microarray DataChip platform would be screening of metabolic pathways through an inchip immunofluorescence assays [27] .
Concluding remarks
HT platforms have been a cost-efficient and rapid screening method for evaluating cell-culture additives, including, screening of novel drugs and toxic chemicals in cell culture systems [4, 9, 10, 27] . The current study demonstrates that the DataChip platform has the potential to be utilized for evaluating impact of media additives, on cellular processes, such as, cell growth, metabolism, and productivity. A more detailed metabolic flux analysis, as well as up/down regulation of key signaling pathways using the in-cell immunofluorescence assay developed for the Cell growth in DataChip platform was determined using cell viability assay. Cell growth in shake flask platform was determined by manual cell counting using trypan blue, according to the standard operating protocol provided by J&J, Janssen Biotech. Metabolite analysis on cell-conditioned media collected from the chip samples and shake flask samples were performed using an YSI analyzer. DataChip data represents the mean ± SE of an experiment with 96 replicate microcultures and pooled spent media from the 96 microcultures for metabolite analysis. Shake flask data represents the mean ± standard deviation, where, n = 2 independent experiments.
